ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 157 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 3.13 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $277,000 | -86.6% | 14,709 | -91.6% | 0.00% | -100.0% |
| Q2 2019 | $2,068,000 | -31.2% | 175,664 | -20.2% | 0.00% | -40.0% |
| Q1 2019 | $3,004,000 | +38.8% | 220,064 | +4.2% | 0.01% | +25.0% |
| Q4 2018 | $2,165,000 | -33.5% | 211,183 | +7.9% | 0.00% | -20.0% |
| Q3 2018 | $3,258,000 | +147.6% | 195,695 | +134.9% | 0.01% | +150.0% |
| Q2 2018 | $1,316,000 | +122.7% | 83,300 | +79.1% | 0.00% | +100.0% |
| Q1 2018 | $591,000 | +14.8% | 46,500 | +3.3% | 0.00% | 0.0% |
| Q4 2017 | $515,000 | +3.8% | 45,000 | +11.1% | 0.00% | 0.0% |
| Q3 2017 | $496,000 | +1.4% | 40,500 | -5.2% | 0.00% | 0.0% |
| Q2 2017 | $489,000 | +37.4% | 42,700 | +149.7% | 0.00% | 0.0% |
| Q1 2017 | $356,000 | -15.2% | 17,100 | -15.3% | 0.00% | 0.0% |
| Q4 2016 | $420,000 | +7.4% | 20,200 | +69.3% | 0.00% | 0.0% |
| Q3 2016 | $391,000 | – | 11,931 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 229,895 | $7,593,000 | 6.73% |
| Foresite Capital Management II, LLC | 419,997 | $13,873,000 | 4.65% |
| Cormorant Asset Management, LP | 757,475 | $25,019,000 | 2.99% |
| NEXTHERA CAPITAL LP | 60,000 | $1,982,000 | 2.81% |
| SENZAR ASSET MANAGEMENT, LLC | 557,170 | $18,403,325,000 | 2.05% |
| Parametrica Management Ltd | 9,360 | $309,000 | 2.04% |
| Partner Investment Management, L.P. | 36,756 | $1,214,000 | 1.99% |
| PFM Health Sciences, LP | 1,890,030 | $62,428,000 | 1.90% |
| PYRRHO CAPITAL MANAGEMENT, LP | 63,000 | $2,081,000 | 1.40% |
| BB BIOTECH AG | 1,510,150 | $49,880,000 | 1.40% |